Literature DB >> 16406635

Regulating the regulator: negative regulation of Cbl ubiquitin ligases.

Philip E Ryan1, Gareth C Davies, Marion M Nau, Stanley Lipkowitz.   

Abstract

Cbl proteins are regulators of signal transduction through many pathways and, consequently, regulate cell function and development. They are ubiquitin ligases that ubiquitinate and target many signaling molecules for degradation. The Cbl proteins themselves are regulated by an increasingly complex network of interactions that fine-tune the effects that Cbl proteins have on signaling. The negative regulation of Cbl protein function can occur via cis-acting structural elements that prevent inappropriate ubiquitin ligase activity, degradation of the Cbl proteins, inhibition without degradation owing to interaction with other signaling proteins, deubiquitination of Cbl substrates, and regulation of assembly of the endosomal ESCRT-I complex. Defects in the regulatory mechanisms that control Cbl function are implicated in the development of immunological and malignant diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16406635     DOI: 10.1016/j.tibs.2005.12.004

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  41 in total

1.  Structural basis for autoinhibition and phosphorylation-dependent activation of c-Cbl.

Authors:  Hao Dou; Lori Buetow; Andreas Hock; Gary J Sibbet; Karen H Vousden; Danny T Huang
Journal:  Nat Struct Mol Biol       Date:  2012-01-22       Impact factor: 15.369

2.  c-Cbl deficiency leads to diminished lymphocyte development and functions in an age-dependent manner.

Authors:  Chozhavendan Rathinam; Richard A Flavell
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-19       Impact factor: 11.205

Review 3.  Cbl and human myeloid neoplasms: the Cbl oncogene comes of age.

Authors:  Stephen C Kales; Philip E Ryan; Marion M Nau; Stanley Lipkowitz
Journal:  Cancer Res       Date:  2010-05-25       Impact factor: 12.701

4.  CBL mutations in myeloproliferative neoplasms are also found in the gene's proline-rich domain and in patients with the V617FJAK2.

Authors:  Paula Aranaz; Cristina Hurtado; Ignacio Erquiaga; Itziar Miguéliz; Cristina Ormazábal; Ion Cristobal; Marina García-Delgado; Francisco Javier Novo; José Luis Vizmanos
Journal:  Haematologica       Date:  2012-02-07       Impact factor: 9.941

5.  Ubiquitin over-expression promotes E6AP autodegradation and reactivation of the p53/MDM2 pathway in HeLa cells.

Authors:  Rita Crinelli; Marzia Bianchi; Michele Menotta; Elisa Carloni; Elisa Giacomini; Marzia Pennati; Mauro Magnani
Journal:  Mol Cell Biochem       Date:  2008-07-09       Impact factor: 3.396

Review 6.  Ubiquitination of E3 ligases: self-regulation of the ubiquitin system via proteolytic and non-proteolytic mechanisms.

Authors:  P de Bie; A Ciechanover
Journal:  Cell Death Differ       Date:  2011-03-04       Impact factor: 15.828

7.  c-Cbl facilitates endocytosis and lysosomal degradation of cystic fibrosis transmembrane conductance regulator in human airway epithelial cells.

Authors:  Siying Ye; Kristine Cihil; Donna Beer Stolz; Joseph M Pilewski; Bruce A Stanton; Agnieszka Swiatecka-Urban
Journal:  J Biol Chem       Date:  2010-06-04       Impact factor: 5.157

8.  Met kinase-dependent loss of the E3 ligase Cbl in gastric cancer.

Authors:  Andrea Z Lai; Michael Durrant; Dongmei Zuo; Colin D H Ratcliffe; Morag Park
Journal:  J Biol Chem       Date:  2012-01-18       Impact factor: 5.157

9.  Novel c-CBL and CBL-b ubiquitin ligase mutations in human acute myeloid leukemia.

Authors:  Michael A Caligiuri; Roger Briesewitz; Jianhua Yu; Lisheng Wang; Min Wei; Kristy J Arnoczky; Trent B Marburger; Jing Wen; Danilo Perrotti; Clara D Bloomfield; Susan P Whitman
Journal:  Blood       Date:  2007-05-02       Impact factor: 22.113

10.  Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms.

Authors:  Masashi Sanada; Takahiro Suzuki; Lee-Yung Shih; Makoto Otsu; Motohiro Kato; Satoshi Yamazaki; Azusa Tamura; Hiroaki Honda; Mamiko Sakata-Yanagimoto; Keiki Kumano; Hideaki Oda; Tetsuya Yamagata; Junko Takita; Noriko Gotoh; Kumi Nakazaki; Norihiko Kawamata; Masafumi Onodera; Masaharu Nobuyoshi; Yasuhide Hayashi; Hiroshi Harada; Mineo Kurokawa; Shigeru Chiba; Hiraku Mori; Keiya Ozawa; Mitsuhiro Omine; Hisamaru Hirai; Hiromitsu Nakauchi; H Phillip Koeffler; Seishi Ogawa
Journal:  Nature       Date:  2009-07-20       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.